PHIA Koninklijke Philips N.V.

Siloam Hospitals Group and Philips sign AI capability MoU to support Indonesia’s healthcare transformation strategy

Siloam Hospitals Group and Philips sign AI capability MoU to support Indonesia’s healthcare transformation strategy

October 7, 2024

Jakarta, Indonesia and Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Siloam Hospitals Group, Indonesia’s leading private healthcare provider, have signed a Memorandum of Understanding (MoU) to advance AI capabilities and development in the healthcare sector in Indonesia.

The strategic collaboration, in partnership with the Universitas Pelita Harapan (UPH) Medical Sciences Group, will focus on capacity building, knowledge sharing, and implementing advanced AI solutions. Leveraging Philips’ AI innovations, the collaboration will help transform clinical care and digital health, enhance healthcare delivery and make the healthcare infrastructure more sustainable. The goal is to deliver better care for more people in Indonesia.

This partnership aligns with the Indonesian government’s healthcare strategy to improve healthcare accessibility, enhance clinical outcomes, and embrace digital transformation.

Key areas of focus in the partnership:

1. AI-driven clinical care: Philips intends to introduce its cutting-edge AI technologies into Siloam Hospitals, particularly in areas such as radiology, pathology, (interventional) cardiology and clinical operations. AI will enhance clinical decision-making and improve workflows, enabling healthcare professionals to diagnose and treat patients with greater precision and to enhance capacity of the system to be able support more patients.

2. Capacity building and local AI expertise: The MoU will focus on the development of local expertise in AI and digital health through collaboration with the UPH Medical Sciences Group. This initiative includes training programs to enable healthcare professionals, IT specialists and UPH students with the necessary skills to develop and apply AI in clinical settings.

3. Global knowledge sharing with Philips: As a global leader in informatics and AI for healthcare, Philips will share its expertise and global best practices with Siloam Hospitals and UPH. The collaboration includes aligning with Philips’ informatics, AI research and global healthcare strategies to create scalable solutions tailored to the needs of Indonesia’s healthcare system.





4. Digital health transformation: In support of Indonesia’s digital health strategy, Siloam Hospitals will integrate AI into its healthcare management systems, including telemedicine, electronic medical records, and remote patient monitoring. The use of AI will improve patient outcomes, optimize hospital operations, increase capacity and provide patients with personalized, data-driven care, even in remote areas.

5. Supporting the Indonesian government’s healthcare goals: The intended partnership aligns with the Indonesian government’s strategy to enhance healthcare accessibility and quality.

6. Expertise sharing for driving ESG in healthcare: Philips will support Siloam Hospitals in advancing its ESG strategic priorities, including sustainability in the supply chain, environmental stewardship, fostering an equitable workplace, and expanding healthcare access and education.

Quotes from key leaders:

Caroline Riady, Deputy President Director of Siloam Hospitals Group: “This partnership with Philips, Siloam Hospitals and Universitas Pelita Harapan is a significant milestone in our journey to bring advanced healthcare technologies to Indonesia. By investing in AI capability and sharing global expertise, we are helping to build a smarter, more efficient healthcare system that will benefit millions of Indonesians and support the national healthcare agenda.”

Roy Jakobs, Chief Executive Officer of Royal Philips: “At Philips, we believe that informatics and AI will help transform healthcare by optimizing workflows, improving efficiency and increasing capacity – making healthcare more accessible and delivering better care for more people. We are excited to collaborate with Siloam Hospitals and Universitas Pelita Harapan to drive this transformation and fully support the Indonesian government’s vision of improving healthcare through digital innovation.”

Rosan Roeslani, Minister of Investment of the Republic of Indonesia: “The future of healthcare is digital, and AI will play a crucial role in revolutionizing how care is provided. The partnership between Philips and Siloam Hospitals, which allows Indonesia to build local capabilities while tapping into global advancements in AI technology, is an exemplary collaboration to ensure the future economic development and sustainability of Indonesia.”

For further information, please contact:

Mark Groves

Philips External Relations

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 68,700 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachment



EN
07/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips advances remote imaging leadership with FDA 510(k) clearance f...

Philips advances remote imaging leadership with FDA 510(k) clearance for innovative remote scanning and protocol management capabilities November 22, 2024 Vendor-agnostic, multi-modality Radiology Operations Command Center (ROCC) connects technologists, radiologists, and operations teams in real timeNew FDA 510(k) cleared remote scanning and protocol management help improve the operation of radiology workflows Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major step forward in making radiology expertise for  diagnostic imagin...

 PRESS RELEASE

Philips unveils next-generation BlueSeal helium-free MRI system, integ...

Philips unveils next-generation BlueSeal helium-free MRI system, integrated with AI-enabled Smart Reading at #RSNA24 Nov. 21, 2024 Industry’s first wide bore, high-performance helium-free [1] 1.5T MR features AI assistance at every step in the MRI workflow, with seamless integration of cloud-based AI image reading and reporting tools on the MR scanner Philips BlueSeal helium-free magnet combined with compact and lightweight design allows flexibility of installations in difficult and remote locations to improve wider access to advanced MRIPhilips’ award-winning [2] AI-based SmartSpeed image...

 PRESS RELEASE

Philips Spectral CT 7500 RT, world’s first spectral 4DCT respiratory-g...

Philips Spectral CT 7500 RT, world’s first spectral 4DCT respiratory-gated imaging receives FDA 510(k) clearance November 12, 2024 Designed specifically for use in radiation oncology, new Spectral CT 7500 RT enables personalized radiation therapy planning to deliver better care for more cancer patients Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major advance in radiation oncology with 510(k) clearance from the US Food and Drug Administration (FDA) for its new detector-based spectral computed tomography (CT) radiotherapy s...

 PRESS RELEASE

Philips enrolls first patient in U.S. clinical trial for innovative in...

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD)Cardiovascular Institute of the South successfully treats first patient in the U.S. using Philips’ innovative laser system, marking a milestone in advancing personalized care for PAD patients Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a gl...

Oscar Rodriguez
  • Oscar Rodriguez

PHILIPS: MENSAJES DE LA CONFERENCE CALL RDOS. 3T’24 (ANÁLISIS BANCO SA...

De la conference call de Rdos. 3T’24 destacamos los siguientes mensajes:

ResearchPool Subscriptions

Get the most out of your insights

Get in touch